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Abstract: MicroRNAs (miRNAs) are non-coding RNAs that bind to target mRNA leading to translational arrest or mRNA 
degradation. To study miRNA-mediated regulation of osteogenesis and chondrogenesis, we compared the expression of 
35 miRNAs in osteoblasts and chondroblasts derived from mouse marrow stromal cells (MSCs). Differentiation of MSCs 
resulted in up- or downregulation of several miRNAs, with miR-199a expression being over 10-fold higher in chondroblasts 
than in undifferentiated MSCs. In addition, miR-124a was strongly upregulated during chondrogenesis while the expression 
of miR-96 was substantially suppressed. A systems biological analysis of the potential miRNA target genes and their inter-
action networks was combined with promoter analysis. These studies link the differentially expressed miRNAs to collagen 
synthesis and hypoxia, key pathways related to bone and cartilage physiology. The global regulatory networks described 
here suggest for the ﬁ  rst time how miRNAs and transcription factors are capable of ﬁ  ne-tuning the osteogenic and chon-
drogenic differentiation of mouse MSCs.
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Introduction
MicroRNAs (miRNAs) are small non-coding RNA-molecules that bind to the 3’ untranslated region 
of mRNAs and, depending on their degree of complementarity with the target genes, induce trans-
lational repression or mRNA degradation.
1 Since the ﬁ  rst identiﬁ  cation of miRNAs in 1993,
2 hun-
dreds of miRNAs have been identiﬁ  ed from plants, animals and viruses.
3 Consecutively, miRNAs 
have proven to play essential roles in diverse biological processes including early development,
4, 5 
cell proliferation and cell death,
6 fat metabolism,
7 cell differentiation,
8, 9 and brain development.
10 
The sequences coding for miRNAs are spread around the genome, including exons, introns, 3’-UTRs 
and genomic repeat-areas, and are situated either in the sense or antisense orientation with respect 
to the overlapping protein-coding gene. Studies carried out with embryonic stem (ES) cells indicate 
that miRNAs expression proﬁ  les in stem cells are different from other tissues,
11 suggesting that 
miRNAs may play an important role in stem cell self-renewal and differentiation. The expression 
of Argonaute genes is restricted to speciﬁ  c anatomical sites in mouse embryos, suggesting that short 
regulatory RNAs may have physiological functions during organogenesis.
5 In addition, miRNAs 
are expressed in haematopoietic tissue where they participate in the regulation of haematopoietic 
stem cell (HSC) differentiation.
9, 12 However, there is only limited amount of information about the 
expression of miRNAs in mesenchymal stromal cells (MSCs) or their potential role in osteo- or 
chondrogenesis.
13
Mesenchymal stromal cells are multipotent cells that have the potential to differentiate to various 
lineages of mesenchymal tissues, including bone, cartilage, adipose, tendon, and muscle.
14 Compared 
to haematopoietic stem cells (HSCs), MSCs are rare in bone marrow, representing ∼1 in 10,000 
nucleated cells. Where HSCs are a well-characterized population of self-renewing cells that give 
rise to all mature blood cell lineages,
15, 16 MSCs are less deﬁ  ned due to the limited understanding 
of MSC properties. As a result, terms such as “marrow stromal cells”, “mesenchymal progenitor 178
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cells”, “nonhaematopoietic mesenchymal stem 
cells” and “adult nonhaematopoietic stem cells” 
are used to deﬁ  ne this cell population. Isolation 
and characterisation of stem cells from bone 
marrow rely on their immunophenotypic or func-
tional aspects. Haematopoietic stem cells have 
been shown to express surface markers CD14 , 
CD34 and CD45.
17 MSCs, on the contrary, lack 
clearly deﬁ  ned surface markers and thus the 
isolation and characterisation of MSCs is still 
based on the properties described by Friedenstein 
already in 1970s: their adherence to plastic, 
spindle-shaped morphology and ability to form 
colonies.
18, 19 In addition, MSCs are commonly 
characterised for their differentiation capacity 
and for the negative expression of haematopoietic 
surface markers.
In calciﬁ  ed tissue, MSCs are needed for bone 
and cartilage formation. During embryogenesis, 
bone formation begins with mesenchymal stem 
cell condensation. Membranous bone (craniofa-
cial bones and the clavicle) is derived from MSCs 
that differentiate in situ into bone-forming osteo-
blasts and produce matrix rich in Type I collagen. 
Endochondral bone, which is the principal type 
of bone in the body, is formed by MSCs that ﬁ  rst 
differentiate into chondrocytes to form a carti-
lagenous template for the bone. Chondrocytes 
secrete a matrix rich in Type II collagen and 
Aggrecan, and go through a genetic program 
driven by Sox9
20 leading to cartilage enlarge-
ment. In the centre of the cartilage anlage, chon-
drocytes become hypertrophic and start to 
synthesise Type X collagen that is later degraded 
and replaced by bone. Although transcription 
factors such as Sox9 and Runx2, and signalling 
molecules such as Indian hedgehog (Ihh), 
Parathyroid hormone-related protein (PTHrP), 
Fibroblast growth factors (FGF), and Bone mor-
phogenetic proteins (BMPs) are involved in the 
regulation of endochondral bone formation,
21 the 
molecular mechanisms leading to bone formation 
are still poorly understood. Thus, understanding 
the regulatory networks that control the lineage 
commitment and differentiation of MSCs is an 
important challenge.
In order to study the role of miRNAs in osteo- 
and chondrogenesis, miRNA expression proﬁ  les 
of osteoblasts and chondroblasts derived from 
mouse MSCs were compared. Subsequently, tar-
get prediction studies carried out with the dif-
ferentially expressed miRNAs were combined 
with pathway analyses to gain more insight into 
the cellular functions potentially regulated by 
these miRNAs. Bioinformatics studies have 
shown that the promoter regions of miRNAs seem 
to contain similar regulatory motifs as the pro-
moter regions of protein coding genes.
22 In order 
to investigate whether the studied miRNAs could 
form regulatory networks with transcription fac-
tors (TFs) involved in osteo- or chondrogenesis, 
the promoter regions of the differentially 
expressed miRNAs were analysed. We present 
here multiple lines of evidence to suggest that in 
addition to haematopoietic cells, miRNAs are also 
involved in the regulation of lineage commitment 
in mesenchymal cells.
Materials and Methods
Cell culture and RNA extraction
All cell culture reagents, unless otherwise stated, 
were purchased from Gibco Invitrogen (U.S.A.). 
Total RNA was extracted from cultured cells 
before and after osteo- or chondrogenic induction 
using the mirVana miRNA Isolation Kit following 
the manufacturer’s protocol (Ambion, U.S.A.). 
To remove genomic DNA contamination, total 
RNA samples were digested with DNase I (NEB, 
U.S.A.). RNA concentrations were quantified 
using an Eppendorf Biophotometer (Eppendorf, 
U.S.A.).
Bone marrow cells were isolated from 8–12 
week-old male C57BL × DBA mice according to 
a previously described method.
23 Brieﬂ  y, cells 
were isolated from the tibiae and femora by ﬂ  ush-
ing them from the bone marrow cavity using a 
10 ml syringe with a 25 gauge needle and medium 
consisting of RPMI-1640, 12% iFCS, 100 U/ml 
penicillin and 100 µg/ml streptomycin. A primary 
culture of plastic adherent cells from mouse bone 
marrow is a heterogeneous population of mesen-
chymal and hematopoietic stem cells.
24 For the 
selection of mesenchymal stem cells, bone mar-
row cells were incubated 2 hours at 37 ºC on a 
plastic culture dish containing RPMI-1640 
medium described above (12% iFCS, 100 U/ml 
penicillin and 100 µg/ml streptomycin) to remove 
rapidly adherent cells.
18, 19 Unattached cells were 
collected and cultured in cell culture ﬂ  asks at the 
initial density of 1 × 10
6 cells/cm
2. Non-adherent 
cells were removed 48 hours later and adherent 
cells were washed with phosphate-buffered saline 179
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(PBS). Cells were further cultured with a twice-
weekly medium replacement (half of the medium 
replaced). When conﬂ  uent, cells were detached 
using trypsin-EDTA and re-plated at the density 
of 10 000 cells/cm
2. RPMI medium has been 
demonstrated to inhibit the growth of hemato-
poietic cells in culture
25 and cultures were there-
fore maintained in RPMI-1640 for 1 to 2 weeks.
26 
Finally, adherent cells were detached by a 
trypsin-EDTA treatment and expanded by plating 
them in DMEM medium supplemented with 12% 
iFCS, 100 U/ml penicillin and 100 µg/ml 
streptomycin at the density of 1  000 cells/cm
2. 
Cells were cultured in described medium 
until conﬂ  uent (1 to 2 weeks), thereafter trypsin-
ized, immunophenotypically characterised and 
subjected to osteoblastic or chondrogenic 
differentiation.
For immunophenotypic characterisation, MSCs 
were plated on chamber slides, cultured to conﬂ  u-
ency and then stained for surface markers Ly-6A/E 
stem cell antigen 1 (Sca-1) (BD Biosciences, 
U.S.A.), CD34 (Vision Biosystems, U.S.A.) and 
CD45 (Dako, Denmark). Cells were incubated for 
1 hour with primary antibodies against Sca-1 
(1:100), CD45 (1:100) and CD34 (1:400) diluted 
in DAKO ChemMate Antibody Diluent (Dako, 
Denmark). Cells were washed with TNT-buffer 
(0.1 M Tris pH 7.5, 0.15 M NaCl, 0.05% Tween20) 
and incubated with Post-Blocking reagent 
(DPVO+500Post, Immunovision Technologies 
Co., Netherlands) for 20 minutes. Cells were 
washed three times with TNT buffer and incubated 
with Poly-HRP anti-Mouse IgG (Immunovision 
Technologies Co., Netherlands) for 30 minutes. 
The secondary antibody was detected with DAB 
(Zymed Invitrogen, U.S.A.) and nuclei were coun-
terstained with Mayer’s hematoxylin.
Osteogenic differentiation was induced by 
culturing the long-term selected MSCs in osteo-
genic medium consisting of phenol red-free α-
MEM, 12% iFCS, 10 mM Na-β-glycerophosphate 
(Fluka BioChemika, Switzerland), 50 µgrams/ml 
ascorbic acid 2-phosphate (Sigma-Aldrich, 
U.S.A.), 100 U/ml penicillin and 100 µg/ml strep-
tomycin for 3 weeks in cell culture ﬂ  asks and 
24-well plates at the initial density of 10 000 
cells/cm
2. During the first week, the culture 
medium was supplemented with 10 nM dexa-
methasone. The cultures were terminated by RNA 
extraction or ﬁ  xation in 3% paraformaldehyde. To 
demonstrate osteoblastic differentiation, cells 
were stained for alkaline phosphatase (ALP) 
(Sigma-Aldrich, U.S.A.) and bone nodules were 
detected by von Kossa staining.
27 To induce chon-
drogenic differentiation, 200 000 of the cultured 
MSCs were placed in a 15-ml polypropylene tube 
and centrifuged (6 min 500 × g) to form a micro-
mass pellet culture.
28 Cell pellets were cultured 
for 21 days in chondroinductive medium consist-
ing of high-glucose DMEM supplemented with 
10 ng/ml TGF-β3 (R&D Systems, UK), 10
−7 M 
dexamethasone, 50 µg/ml ascorbic acid 2-phosphate, 
40 µg/ml L-proline (Sigma Aldrich, U.S.A.), 
100 µg/ml sodium pyruvate (Sigma Aldrich, 
U.S.A.), 50 mg/ml ITS+ Premix (BD Biosciences, 
U.S.A.). Media were changed every 3 to 4 days. 
After three weeks of culture, the pellets were either 
lysed for RNA extraction or ﬁ  xed for 2.5 hours in 
4% paraformaldehyde. To evaluate chondrogenic 
differentiation, pellets were embedded in parafﬁ  n, 
cut into 5 µm sections and stained with toluidine 
blue for proteoglycans. Presence of type II col-
lagen was detected by 6B3 monoclonal antibody 
raised against chicken type II collagen
29 following 
the method described earlier.
30
Osteogenic and chondrogenic 
gene expression
To further conﬁ  rm the osteogenic and chondro-
genic differentiation of the long-term selected 
MSCs, the total RNAs were analyzed with RT-PCR 
for the expression of selected osteogenic and chon-
drogenic transcripts (Table S1). The osteogenic 
genes included Type I collagen, Osteocalcin, 
Osterix (Sp7), and Runx2, whereas chondrogenic 
differentiation was evaluated based on the expres-
sion of Type II and X collagens and Sox9. One µg 
of DNase I treated total RNA was reverse tran-
scribed using M-MLV reverse transcriptase 
(Promega Corporation, UK). cDNAs were ampli-
fied using DyNAzyme II DNA Polymerase 
(Finnzymes, Finland) for 35 cycles and analysed 
on 1,5% agarose gel. Ampliﬁ  cation of GAPDH and 
L19 served as loading controls.
miRNA expression
A total of 35 miRNAs were selected for the 
follow-up based on their expression in haema-
topoietic tissues
9, 31, 32 or mouse embryonic stem 
(ES) cells
11 or based on computational predic-
tions on physiologically important genes related 180
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to bone and cartilage function (Table S2). The 
expression profiles of these miRNAs 
were detected by quantitative real-time PCR 
(qRT-PCR). Amplifications were performed 
using Taq DNA Polymerase (ABgene) and mir-
Vana qRT-PCR miRNA Detection Kit (Ambion, 
U.S.A.) following the manufacturer’s instruc-
tions. For each sample, a total of 37 different 
reactions were performed in triplicate with 
mirVana qRT-PCR Primer Sets. Out of these, 
35 were specific for miRNAs and two, U6 
snRNA and 5S rRNA, were used for normalisa-
tion. For qRT-PCR reactions, 50 ng of DNAse-
treated total RNA was used and a no-template 
reaction was performed for each primer set. 
RT-reactions, 30 min at 37 ºC followed by 
10 min at 95 ºC, were incubated in MJ Research 
PTC-200. Real-time PCR reactions were per-
formed in MJ Research PTC-200 DNA Engine 
Cycler in optical strips. The reactions were 
incubated at 95 ºC for 3 min, followed by 40 
cycles of 95 ºC for 15 sec and 60 ºC for 30 sec. 
At the end, a dissociation analysis (melt-curve) 
from 56 ºC to 90 ºC was performed. Ct data 
were determined using default threshold set-
tings. End-point reactions were analysed on a 
15% neutral PAGE to discriminate between the 
correct amplification products (∼90 bp) and 
potential primer dimers.
Micro-RNA expression data was normalised to 
U6 snRNA and 5S rRNA according to the manu-
facturer’s recommendations. Relative quantiﬁ  ca-
tion of miRNA expression was calculated with the 
2
−∆∆Ct method
33 where undifferentiated cells were 
set as a calibrator sample. Standard error of the 
normalized expression was calculated by applying 
the differential equation of Gauss.
34 The miRNA 
expression values were compared between undif-
ferentiated and differentiated cells, and between 
osteoblasts and chondroblasts. MicroRNAs, whose 
expression was changed at least 5-fold or 2-fold, 
respectively, were selected for target predictions 
and promoter analyses.
Target predictions
Target prediction tools TargetScan (http://www.
targetscan.org), PicTar (http://pictar.bio.nyu.edu) 
and miRanda (http://www.microrna.org) were 
utilized in order to ﬁ  nd out possible targets genes 
for the differentially expressed miRNAs. Since 
prediction algorithms often result in false positives,
35 
the target gene lists of the three programs were 
combined and an intersection set, including only 
the target genes found with all three prediction 
algorithms, was created for each miRNA sepa-
rately. Predicted target gene identiﬁ  ers were ﬁ  rst 
converted into a common nomenclature, and the 
results were then combined for each miRNA 
separately using data available from the latest 
Ensembl release 44.
Pathway analysis
In order to elucidate the physiological role of 
differentially expressed miRNAs, their target 
genes were analyzed through the use of Ingenu-
ity Pathways Analysis version 5.0 (Ingenuity
® 
Systems, www.ingenuity.com). The intersection 
sets were uploaded into the application, and 
each gene identifier was mapped to its corre-
sponding gene object in the Ingenuity Pathways 
Knowledge Base. The genes in the intersection 
sets were overlaid onto a global molecular net-
work developed from information contained in 
the Ingenuity Pathways Knowledge Base, and 
networks were then algorithmically generated 
based on their connectivity. The functional 
analysis identified the biological functions or 
diseases that were most significant to the inter-
section sets. The significance of the association 
between the intersection set and pathway was 
measured in two ways. First, a ratio of the num-
ber of genes from the intersection set that 
mapped to the pathway divided by the total 
number of genes that mapped to the pathway 
was calculated. Second, Fischer’s exact test was 
used to calculate a p-value determining the 
probability that the association between the 
genes in the intersection set and the pathway is 
explained by chance alone. Graphical represen-
tations of the molecular relationships between 
genes/gene products were also produced. Genes/
gene products were represented as nodes, and 
the biological relationship between two nodes 
was represented as an edge (line). All edges are 
supported by at least 1 reference from the lit-
erature. Nodes were displayed using various 
shapes that represent the functional class of the 
gene product.
Promoter analysis
To examine the potential transcription factors (TFs) 
involved in miRNA regulation, promoter analysis 181
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was performed and conserved binding sites for 
known TFs were predicted for the upstream regions 
of differentially expressed miRNA genes. As target 
prediction algorithms, transcription factor binding 
site (TFBS) prediction tools often result in false 
positives. In order to improve the authenticity of 
the predictions, a technique known as phylogenetic 
footprinting was applied. Thus, human and mouse 
orthological sequences were compared and only 
conserved binding sites were accepted for the 
analysis. Regulatory regions, 500 bp upstream and 
100 bp downstream from the starting locus, of 
human and mouse orthological pre-miRNAs 
(Table S3) were retrieved from Ensemble release 
44. TFBS predictions were performed by Conreal
36 
using high quality vertebrate matrices from 
TRANSFAC professional 9.4.
37, 38
Results
Cell culture
In order to compare miRNA expression in osteo-
blasts and chondroblasts, mesenchymal cells 
were isolated and enriched from bone marrow. 
To conﬁ  rm the negative selection of HSCs and 
the positive selection of MSCs, cells were char-
acterised for the expression of CD34, CD45 and 
Sca-1 surface markers (Fig. 1). After enrichment 
procedure, cells were positive for stem cell 
marker Sca-1
39 and negative for hematopoietic 
surface antigens CD34 and CD45.
17 To compare 
miRNA expression in osteoblasts and chondro-
blasts, long-term selected MSCs were induced 
to differentiate into the desired cell types. For 
osteoblastic differentiation, cells were cultured 
for one to 3 weeks in osteogenic medium, 
followed by alkaline phosphatase- and von Kossa 
stainings (Fig. 2A–D). For chondrogenic differ-
entiation, cells were cultured in chondrogenic 
medium as micromass pellet cultures for 3 weeks, 
followed by histological evaluation. Toluidine 
blue staining demonstrated the presence of pro-
teoglycans and immunohistochemical staining 
showed deposition of type II collagen in the cell 
pellets (Fig. 2E–F).
Osteogenic and chondrogenic gene 
expression
To further evaluate the phenotypes of the in vitro 
differentiated cell cultures, expression of osteo-
genic and chondrogenic genes was analysed with 
RT-PCR (Table S1). After a three-week culture in 
osteoinductive medium, long-term selected MSCs 
expressed osteoblast-related genes Type I collagen, 
Osteocalcin, Osterix and Runx2, but also Type X 
collagen and Sox9. Cells grown in chondroinduc-
tive conditions expressed Runx2, Type II collagen, 
Type X collagen and Sox9, and were negative for 
the expression of Type I collagen, Osteocalcin and 
Osterix (Fig. 2G).
miRNA expression
The mirVana qRT-PCR miRNA Detection Kit 
(Ambion) was used in order to compare miRNA 
expression in osteoblasts and chondroblasts. 
Undifferentiated MSCs were used as a control and 
data were normalized as described in Experimen-
tal procedures. Figure 3 shows the miRNA expres-
sion proﬁ  les of osteoblasts and chondroblasts 
derived from MSCs. Relative expression value of 
Figure 1. Surface antigen expression in MSCs.
Long-term selected MSCs were analysed for the expression of surface antigens CD34 (A), CD45 (B) and Sca-1 (C). Nuclei were counter-
stained with Mayer’s hematoxylin. Bar = 20 µm.182
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Figure 2. Evaluation of osteogenic and chondrogenic differentiation of MSCs
Morphological changes in cells cultured for one (A–B) or three (C–D) weeks in osteogenic medium were evaluated under a light microscope. 
ALP staining (A and C) was used to visualise osteoblasts and von Kossa staining (B and D) demonstrated calciﬁ  cation in the extracellular 
matrix. To induce chondroblast differentiation, cell pellets were cultured in chondrogenic medium (E–F). Toluidine blue staining (E) indicated 
chondrogenic differentiation which was further conﬁ  rmed by immunohistochemical staining for Type II collagen (red staining in F). Bar = 20 µm 
in A–D, and 100 µm in E–F. The capacity of long-term selected MSCs for osteogenic and chondrogenic differentiation was evaluated by 
RT-PCR (G). Total RNA was isolated from cells after osteogenic or chondrogenic differentiation and used for RT-PCR. Ampliﬁ  cation products 
were resolved on a 1,5% agarose gel stained with ethidium bromide. Gapdh and L-19 served as loading controls.183
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Figure 3. miRNA expression in osteoblasts and chondroblasts derived from MSCs.
Relative expression of 35 miRNAs in MSCs after chondrogenic and osteogenic differentiation. 29 miRNAs were selected based on their 
expression in haematopoietic tissues or ES cells, and 6 miRNAs were selected based on target prediction studies. Expression value 1, which 
is marked with a black line, represents miRNA expression in undifferentiated precursor cells. miRNA expression after osteogenic differen-
tiation is shown in blue and expression after chondrogenic differentiation is shown in red. The experiment was repeated twice with three 
replicates for each sample. The data is presented as mean +/− SE. Differentially expressed miRNAs (marked with arrows) were selected 
for further analysis.
Table 1. Differentially expressed miRNAs in MSC-derived osteoblasts (O) and chondroblasts (C).
Comparison of osteoblasts and chondroblasts to MSCs (at least 5-fold difference)
Osteoblasts Expression  relative Chondroblasts Expression  relative
  to  MSCs  to  MSCs
miR-24 7,66  miR-18 0,44  ↓
miR-199b 5,30  miR-24 5,54
   miR-96 0,13  ↓
   miR-101 5,66
   miR-124a 8,18
   miR-199a 12,13
   miR-199b 7,46
Comparison between osteoblasts and chondroblasts (at least 2-fold difference)
O vs. C  Ratio  C vs. O  Ratio
miR-18 2,65  miR-124a 3,50
miR-31 3,05  miR-130a 2,61
miR-96 5,73  miR-142-3p 2,35
miR-130b 3,31 miR-199a 5,25184
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1 represents the expression level of a speciﬁ  c 
miRNA in undifferentiated MSCs. Only 2 out of 
35 miRNAs were differentially (5-fold) 
expressed in osteoblasts compared to the undif-
ferentiated cells whereas in chondroblasts the 
expression levels of 7 out of 35 miRNAs changed 
at least 5-fold during the differentiation (Table 1). 
In addition, 8 out of 35 miRNAs were differen-
tially expressed (at least 2-fold) between osteo-
blasts and chondroblasts derived from long-term 
selected MSCs (Table 1).
Pathway analysis
Intersection sets (Fig. 4) of potential miRNA target 
genes were uploaded into Ingenuity Pathways 
Analysis version 5.0 (Ingenuity
® Systems, www.
ingenuity.com), resulting in multiple interaction 
networks. An exceptionally high score and low 
p-value, as calculated by IPA, was observed for 
5 miRNAs out of 11 and the most signiﬁ  cant bio-
logical functions related to individual miRNA 
target gene pathways are shown in Table 2.
Promoter analysis
Information about eukaryotic transcription factors, 
their genomic binding sites and DNA-binding 
proﬁ  les is stored in databases such as TRANS-
FAC
37 and JASPAR.
40 The upstream regions of 
differently expressed miRNA genes (Table S2) 
were analysed in order to study the potential tran-
scription factors (TFs) involved in miRNA regula-
tion. When the results were combined with data 
obtained from target predictions and IPA analyses, 
it could be noted that 3 transcription factors (PBX1, 
PPARγ and HIF1α) that were predicted as targets 
for the differentially expressed miRNAs had also 
binding sites in the upstream region of the same 
miRNAs (Table S4). PBX1 (pre-B-cell leukemia 
homeobox) is a potential target for miR-101 that 
was over 5-fold upregulated in chondroblasts. 
PPARγ (peroxisome proliferator-activated recep-
tor γ) is potentially regulated by miR-130b that 
came up when comparing the miRNA expression 
between osteoblasts and chondroblasts. HIF1α was 
predicted to be regulated by miR-199a that was 
over 12-fold upregulated in chondroblasts.
When the interplay of miRNA target genes and 
TFs was analysed on the basis of published obser-
vations, a global regulatory network could be 
observed (Fig. 4B). miR-199a that was upregulated 
in chondroblasts was found to target HIF1α. 
miR-124a was also upregulated in chondroblasts 
with RFX1 as its target. miR-96 expression was 
strongly suppressed in chondroblasts, and it was 
found to target SOX5, a transcription factor that 
controls chondrogenesis. The previously described 
cartilage-speciﬁ  c miR-140 target HDAC4
41 could 
also be explained by the regulatory network 
presented in Figure 4, yet the expression of miR-
140 remained constant in our experiments. When 
the existence of genomic miRNA clusters were 
analysed for the miRNAs studied here, two miR-
NAs were found to be located in clusters, namely 
miR-199a/miR-214 and miR-96/miR-182/miR-
183. These clusters may strengthen the regulation 
of Sox5-Sox6 axis leading to type II collagen 
responses, or of HIF1α-PGF-axis leading to vari-
ous hypoxia responses (Fig. 4).
Discussion
Although miRNAs have been shown to play an 
important role in cell differentiation, their contribu-
tion to osteo- or chondrogenesis has not been 
previously demonstrated. We present here multiple 
lines of evidence to suggest that miRNAs are an 
integral part of the transcription factor network 
regulating bone marrow stem cell differentiation 
and proliferation. Promoter analyses and target 
predictions carried out with differentially expressed 
miRNAs show that transcription factors may act 
as direct miRNA targets, but also as upstream 
regulators of miRNA target genes, or the miRNAs 
themselves. This way they constitute loops that 
strengthen or attenuate regulatory events.
Since there was no previous data about miRNA 
expression in mesenchymal stromal cells, we 
selected the miRNAs for this experiment based on 
their expression in haematopoietic tissue. We 
hypothesised that the haematopoietic miRNAs may 
also target genes involved in the differentiation of 
mesenchymal tissue within the bone marrow 
microenvironment. Haematopoietic miRNAs were 
supplemented with miRNAs found from mouse 
embryonic stem cells and with miRNAs selected 
based on target prediction studies carried out with 
genes involved in bone or cartilage function. In 
addition, miR-140 was included based on its sug-
gested role in chondrogenesis.
41
To gain more insight into the cellular functions 
possibly affected by the studied miRNAs, the 
predicted target genes of the differently expressed 185
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Figure 4. Intersection sets of the differentially expressed miRNAs constitute complex interaction networks.
A Venn diagram illustrating the production of intersection sets from three miRNA target prediction algorithms. Differentially expressed miRNAs 
were selected for miRNA target predictions by PicTar, TargetScan and miRBase. Intersection lists containing 8–107 predicted miRNA target 
genes (mean 63 genes) were then uploaded to Ingenuity Pathways Analysis (IPA) for further interaction network analysis. The miRNA target 
genes were overlaid onto a global molecular network developed from information contained in the Ingenuity Pathways Knowledge Base 
(www.ingenuity.com), and networks were then algorithmically generated based on their connectivity. Results from pathway analysis were 
combined with promoter analysis data to form a global regulatory network, as shown in the Figure. Composite loops (Shangi et al. 2007) 
were observed for three TFs marked with red nodes (PBX1, PPARγ and HIF1α); these harboured TFBSs in upstream regions of miRNAs 
while they were also predicted as target genes for the same miRNA. Two miRNA clusters that were found to target signiﬁ  cantly interacting 
genes are marked in the Figure with rectangles. Arrows represent miRNAs that are predicted to regulate a speciﬁ  c gene. Nodes are displayed 
using various shapes that represent the functional class of the gene product.
Ingenuity  Pathways  Analysis and Promoter Analysis
PGF186
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Table 2. Systemic analysis of speciﬁ  c biological functions related to predicted miRNA target genes.
miRNA Speciﬁ  c biological functions  −log(p-value) Focus  genes
miR-96 Developmental  disorder  5,0  13
 Cellular  movement  4,1  10
  Cellular assembly and organisation  4,0  18
 Cell  morphology  4,0  17
  Connective tissue development and function  4,0  10
 Cancer  3,2  14
  Small molecule biochemistry  3,0  19
 Lipid  metabolism  3,0  11
 Genetic  disorder  2,5  10
miR-124a Cancer  3,5  11
 Cellular  development  3,0  16
 Cellular  movement  2,5  14
miR-130a Cellular  movement  5,2  13
 Cell  signalling  3,3  18
 Gene  expression  3,0  14
miR-130b Cell  cycle  4,5  12
 Cell  death  3,5  15
 Cellular  movement  2,8  12
miR-199a Cell  death  4,9  10
 Cancer  3,0  10
A total of 79 biological functions were evaluated for each miRNA intersection set by Ingenuity Pathways Analysis. The statistically signiﬁ  cant 
biological functions with 10 or more focus genes (target genes of a given miRNA) are listed here.
miRNAs were analysed. We hypothesised that 
if miRNA target genes are physiologically 
relevant, they should produce significant 
interaction networks in the pathway analysis. 
Extremely low p-values and extensive interac-
tions between genes predicted as miRNA targets 
were observed, which cannot be explained by 
chance alone. Bioinformatics’ approaches have 
suggested that miRNA expression may be 
regulated by transcription factors.
42 When 
the interaction networks between miRNAs 
and transcription factors were computation-
ally studied, thousands of human genes 
were suggested to be regulated by miRNA-TF 
interactions.
43 As miRNAs are known to target 
many TFs, the regulatory network appears to be 
very complex. Composite loops
43 were observed 
in our analysis for 3 TFs: PBX1, PPARγ and 
HIF1α. These harboured binding sites in the 
upstream region of miRNAs while they were 
also predicted as target genes for the same miRNA. 
In addition, numerous TF binding sites were 
observed in the upstream regions of the differ-
entially expressed miRNAs.
It became obvious from these analyses that only 
a fraction, if any, of the miRNA responses are such 
that lead to a single, easily predictable outcome 
in cells. Instead, accumulation of several miRNA 
responses eventually may lead to physiological 
responses (Fig. 5). An example of such a response 
is the downregulation of Type I collagen expres-
sion by miR-124a. The TF RFX1 (Regulatory 
factor X1) is a target of miR-124a, which was 
upregulated in chondroblasts. Another example is 
Sox5, which regulates Type II collagen expression 
during chondrogenesis but also lipase expression, 
raising the possibility that Sox5 has also a role in 
adipogenesis and lineage commitment. In MSC 
cultures, β-glycerophosphate and ascorbic acid 
induce osteoblast formation and lead to miR-96 
upregulation. During osteoblastic differentiation, 
adipocyte or chondrocyte genes, like Sox5-regu-
lated lipase or Type II collagen, must be turned 
off e.g. by miR-96 in favour of osteogenic differ-
entiation. The complex regulatory networks 
described here indicate that miRNA-TF interac-
tions are powerful modulators of bone marrow 
stromal cell differentiation. The speciﬁ  c biological 
functions related to the target genes of differen-
tially expressed miRNAs suggest that they are 
involved in developmental pathways including 
cellular development and movement, cell mor-
phology, cell signalling, cell death, and connective 
tissue development and function.187
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Figure 5. Model for miRNA-TF interactions during the differentiation of bone marrow stromal cells into bone-forming osteoblasts 
or chondroblasts.
Multiple lines of evidence suggest that miRNAs substantially downregulated in chondroblasts targeted genes important for chondrogenic 
differentiation. In addition, miRNAs signiﬁ  cantly upregulated in chondroblasts appeared to target genes important for osteogenesis, adipo-
genesis and myogenesis. PPARγ (involved in adipogenesis) was targeted by miR-130a and miR-130b that were upregulated in chondroblasts 
and osteoblasts, respectively. PBX1 (involved in myogenesis) is a potential target for miR-101 that was over 5-fold upregulated in chondro-
blasts. Osteoblasts were positive for miR-96 that downregulated Type II collagen expression via Sox5. Chondroblasts were positive for 
miR-124a that regulates Type I collagen expression via RFX1. HIF1α was targeted both by miR-18a (expressed in osteoblasts) and miR-
199a (expressed in chondroblasts), suggesting that hypoxic signals are important regulators of MSC differentiation. At the tissue level sig-
niﬁ  cant physiological responses may be seen already by affecting the balance between these miRNAs and their target genes. How these 
regulatory pathways that seem to be important in MSC differentiation can be utilised e.g. in regenerative medicine remain to be resolved.
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Table S1. PCR primers used for osteogenic and chondrogenic gene ampliﬁ  cation.
Gene symbol  Forward primer  Reverse primer  Amplicon size
GAPDH aggtgaaggtcggagtcaacg  gctcctggaagatggtgatgg  232  bp
RPL19 ctgaaggtcaaagggaatgtg  ggacagagtcttgatgatctc  195  bp
COL1A1 gaagtcagctgcatacac  aggaagtccaggctgtcc  312  bp
BGLAP (Osteocalcin) ctgctcactctgctggccctgg ggcggtcttcaagccatactgg  243  bp
SP7 (Osterix) actcatccctatggctcgtg  ggtagggagctgggttaagg  238  bp
RUNX2 ccgcacgacaaccgcaccat  cgctccggcccacaatctc  289  bp
COL2A1 agagacctgaactgggcaga  gcaccattgtgtaggacacg  201  bp
COL10A1 cctgcagcaaaggaaaactc  tggcttaggagtgggagcta  179  bp
SOX9 cgactacgctgaccatcaga  agactggttgttcccagtgc  188  bp
Table S2. MicroRNA predictions on target genes related to osteoblast and chondrocyte function.
Target gene  Description  miRNA ID
Osteoblastic genes  
COL1A1  Type I collagen  miR-29a, miR-150, miR-185
BGLAP Osteocalcin  –
RUNX2  Runt-related transcription factor  –
Chondrogenic genes  
COL2A2  Type II collagen  miR-7, miR-29a, miR-29b
COL10A1 Type  X  collagen  miR-101
SOX9  SRY (sex determining region Y)-box 9  miR-101, miR-124
Target predictions for the selected genes were carried out with TargetScan, PicTar, or miRanda miRNA target prediction tools.
MicroRNAs Regulate Osteogenesis and Chondrogenesis 
of Mouse Bone Marrow Stromal Cells
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